Top Venous Stents Companies

The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation.

• Oxford Endovascular (2015, UK): Oxford Endovascular, a University of Oxford spin-out, is developing stent technology based on origami to treat brain aneurysms. The nickel-titanium alloy stents are potentially foldable into less invasive packages and could be delivered through microcatheters. When deployed to repair dilated blood arteries, they expand. The technology beneath has the potential to be applied to venous procedures as well, providing new solutions for complex vascular issues, although their current focus is on neurovascular applications.

• Oxford Heartbeat (2015, UK): Oxford Heartbeat has created advanced software that creates 3D models of a patient's cerebral blood arteries using 2D medical imaging. This increases stent placement accuracy and reduces the risk of complications by allowing surgeons to model and select the best stent for each case. This method was initially used on cerebral arteries, but it could possibly be used for venous systems as well and enhance the effects of venous stenting treatment through personalized planning.

Top Player’s Company Profiles

• Boston Scientific Corporation

• Medtronic Plc

• Becton, Dickinson and Company

• Cook Medical

• Gore Medical

• Abbott Laboratories

• Vesper Medical

• Optimed Medizinische Instrumente GmbH

• BIOTRONIK SE & Co. KG

• Bentley InnoMed GmbH

• Cordis Corporation

• Plus medica GmbH & Co.

• Philips Healthcare

• Stryker Corporation